Vaccine Company, Inc. (Vaccine Company), a privately held pre-clinical-stage biotechnology company developing next-generation vaccines for infectious diseases, today announced entry into a definitive ...

By Sriparna Roy May 26 (Reuters) - Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to $3.8 ...

The Big Pharma is paying up to $1.5 billion, split between an upfront fee and a milestone payment, to buy shingles vaccine ...

Eli Lilly agreed to buy three vaccine developers targeting shingles, bacterial infections and Epstein-Barr Virus.

The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr ...

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital ...

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital ...

Around 90% of people are infected with Epstein-Barr virus at some point in their lifetimes. For most of them, the virus causes a mild, transient illness or no symptoms at all. But for a subset of ...

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study ...

Over 95% of the world’s adult population is infected with Epstein–Barr virus (EBV), but most people never realise it. The infection often causes few symptoms and then stays in the body for life. But ...